Poll: 1 in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Drugs Are Difficult to Afford Most Doubt the Trump Administration Will Lower Drug Costs for People Like Them, Though Three-Fourths of Republicans Expect It Will About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds
For consumers who want more than fiber alone, the GLP-1 Booster offers additional value, making them feel that they are getting more for their money
some plans require prior authorization or dont cover weight loss medications Saxenda: Moderate coverage
(2025, June 30)
Counterfeit drugs often lack efficacy, pose health hazards, and erode brand reputation for innovator companies
I have never seen any published studies testing absorption through a patch, only by injection, says Dr
